|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1995;59:613
© 1995 The Society of Thoracic Surgeons
Division of Circulatory Physiology, Columbia-Presbyterian Medical Center, 177 Fort Washington Ave, MHB 5-435, New York, NY 10032
| The first 20% of the full text of this article appears below. |
See also page 609.
Left ventricular assist devices (LVADs) have shown increasing promise in the treatment of end-stage heart disease. However, most studies have focused on their use as a bridge to transplantation. In contrast, this article by McCarthy and associates raises a timely and important question about the utility of these devices in engendering return of native heart function rather than supporting the patient until the heart is replaced. Unfortunately, they conclude that although there is a marked decrease in ventricular size immediately after LVAD implantation, there is little
Related Article
Ann. Thorac. Surg. 1995 59: 609-613.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |